Response to Comments: MolDX: Next-Generation Sequencing for Solid Tumors

This document is a response-to-comments for MolDX LCD L38119 (Next-Generation Sequencing for Solid Tumors) and does not itself establish clinical coverage rules; consult LCD L38119 for coverage indications. The referenced Article A57900 (defining 'primary cancer') has been retired and not replaced or adopted by Noridian. The LCD notice period began 2020-04-02 and the policy became effective 2020-05-17.

"Article A57900 (definition of 'primary cancer') has been retired and is not available as guidance; Noridian has not adopted or implemented A57900."

Sign up to see full coverage criteria, indications, and limitations.